Metabolic Pathway

Retatrutide — molecular reference

Retatrutide is a synthetic 39-amino-acid peptide that engages three incretin-family receptors — GLP-1R, GIP-R, and the glucagon receptor — simultaneously. Research groups use it in receptor binding and downstream cAMP / β-arrestin recruitment assays to characterize the balanced pharmacology of tri-agonists relative to dual (GLP-1/GIP) and mono agonists. Its extended half-life analog design supports in-vitro stability and comparative potency work in cultured adipocyte and hepatocyte models. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.

Molecular data

Compound name: Retatrutide (GLP-1 / GIP / Glucagon Triple Agonist)
Also referenced as: GLP-3
Research classification: Peptide Hormone & Analog
Molecular formula: C221H342N46O68
Average molecular mass: ≈ 4731 Da(published value)
Research pathway: Metabolic Pathway
Physical form: Lyophilized powder
Storage & handling: Store lyophilized at -20°C. Protect from light.
Available presentations: 10mg · 20mg · 30mg · 50mg
Current status: In Stock

Fields with no verifiable source are omitted rather than estimated. Where an average mass is marked as calculated, it is derived arithmetically from the molecular formula using IUPAC standard atomic weights, not measured.

Documented assay contexts

Contexts in which this compound is used as a reference material in published in-vitro work. These describe laboratory usage, not effects in any organism.

GLP-1/GIP/glucagon receptor signaling
cAMP downstream assays
Metabolic pathway modeling

Lot documentation

Lot	Presentation	Purity	Certificate
PH260501	10mg	99.9%	View certificate
PH260502	20mg	99.9%	View certificate
PH260503	30mg	99.9%	View certificate
PH260806	50mg	—	Testing in progress

Retatrutide — molecular reference

Molecular data

Documented assay contexts

Lot documentation

Related Pure Helix research

Other metabolic pathway compounds